Development and consolidation of 10 scientific projects in animal models and humans in the field of neuropharmacology, molecular biology, biotechnology, neuropsychiatry and addictions; projects that gave rise to the design, development and application of vaccines for the treatment of the most outstanding addictions worldwide and medical treatments to prevent craving and dependence on the abuse of psychoactive drugs. Development and implementation of immunomolecular strategies to identify and clone new opioid molecules in the mammalian brain (1998-2010). Identify a new opioid transmission system in the mammalian brain called Mexneurins (2008-2017). Development of research protocols in the field of perinatal psychiatry with the publication of original articles on psychoneuroimmunological and endocrine findings with international recognition (2013-2020). Publications of more than 100 original scientific works in indexed medical and scientific journals (Current Contents) (1998-).